Researchers launched Sequent to fund under-resourced safety bets after concluding that AI alignment is not on track. The startup focuses on high-risk, neglected research areas that larger labs ignore. This move signals a growing rift between corporate development and independent safety verification. Practitioners should monitor their portfolio for new interpretability benchmarks.